-
On October 10, 2025, President Donald Trump announced a deal with AstraZeneca to lower drug prices for Medicaid patients by matching the lowest prices in developed countries. The agreement includes AstraZeneca's commitment to invest $50 billion in U.S. manufacturing by 2030 and participation in the upcoming TrumpRx website, which will sell discounted drugs directly to consumers starting in early 2026.
-
President Trump’s recent policy, part of the 'big beautiful bill,' blocks Medicaid funding for Planned Parenthood and Maine Family Planning, leading to service disruptions and legal battles. Maine Family Planning will cease primary care services by October 31, affecting nearly 1,000 patients amid ongoing court challenges.
-
Planned Parenthood of Wisconsin resumed scheduling abortions after dropping its 'essential community provider' status, allowing it to receive Medicaid funds under federal law. The move follows federal restrictions on Medicaid funding for abortion providers, impacting access and prompting legal challenges. The organization emphasizes minimal service cost changes and ongoing efforts to maintain access.
-
Alaska's 1970s law restricting abortion to licensed doctors is under legal review after being struck down last year. Planned Parenthood argues advanced practice clinicians can provide safe, effective care, challenging the state's restrictions. The court's decision could impact abortion access in remote communities.